IL17A and neoplasm: Tumor-derived AM promoted, via PI3K/Akt signaling pathway, mast cell degranulation, as well as favored tumor cell proliferation and the blockade of apoptosis in gastric cancer cells; these effects were reverted by blocking the release of interleukin-17A from mast cells [214].